01 1Dipharma Francis S.r.l.
02 1Optimus Drugs Private Limited
01 1CHENODEOXYCHOLIC ACID
02 1Chenodeoxycholic acid
01 1India
02 1Italy
NDC Package Code : 46438-0657
Start Marketing Date : 2019-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59285-033
Start Marketing Date : 2020-07-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Chenodiol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chenodiol, including repackagers and relabelers. The FDA regulates Chenodiol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chenodiol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Chenodiol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Chenodiol supplier is an individual or a company that provides Chenodiol active pharmaceutical ingredient (API) or Chenodiol finished formulations upon request. The Chenodiol suppliers may include Chenodiol API manufacturers, exporters, distributors and traders.
click here to find a list of Chenodiol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Chenodiol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Chenodiol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Chenodiol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Chenodiol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Chenodiol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Chenodiol suppliers with NDC on PharmaCompass.
We have 2 companies offering Chenodiol
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
